Scholars Central

Conference abstractPublished 21 Nov 2013

SPION: Enhanced MR imaging for monitoring Alzheimer�s plaque formation and microglial activation in APP/PS-1 transgenic mouse brain

Authors: Laurel O. Sillerud

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

We report MRI studies in APP/PS1 transgenic mice, which demonstrate the ability of our novel anti-amyloid precursor protein (APP) conjugated superparamagnetic iron oxide nanoparticles (SPIONs) to penetrate the blood-brain barrier to act as a contrast agent for plaque imaging. The conspicuity of the plaques increased from 5.1�0.5 to 8.3�0.2 when the plaque contrast to noise ratio was compared in control AD mice with SPION-treated AD mice. The number of MRI-detected plaques increased from 347 � 45 in the control AD mice, to 668 � 86 with SPION treatment. AD is associated with a microglia-dependent neuro inflammation regulated by the pro-inflammatory transcription factor NF-κB. We therefore treated APP/PS1 mice for one year with a low dose (100 ppm) of either of two trans-stilbene NF-κB inhibitors, resveratrol, or its synthetic analog, LD55. Both trans-stilbenes lowered Aβ plaque density in the cortex, caudoputamen and hippocampus by 70-100%. Optical measurements confirmed that resveratrol reduced average Aβ plaque density by 2.3 � 0.4-fold. Ex vivo measurements of microglial activation by Iba-1 immunofluorescence showed that resveratrol also reduced average microglial activation by 4.2-fold. The same concentration of our novel trans-stilbene, LD55, produced a significantly larger (p<0.01) reduction in Aβ plaque density than resveratrol (3.1 � 0.5-fold) as well as a 3.5-fold lowering of microglial activation. We conclude that SPION-enhanced MRI can be usefully applied to studies of AD in Tg mice and that both resveratrol and LD55 are efficient at reducing Aβ plaque burden and concomitantly reducing neuro inflammation in AD.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Alzheimers Disease & Parkinsonism.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Laurel O. Sillerud”